Literature DB >> 28753186

Bioactive Whey Protein Concentrate and Lactose Stimulate Gut Function in Formula-fed Preterm Pigs.

Yanqi Li1, Duc Ninh Nguyen1, Karina Obelitz-Ryom1, Anders D Andersen1, Thomas Thymann1, Dereck E W Chatterton2, Stig Purup3, Anne B Heckmann4, Stine B Bering1, Per T Sangild1.   

Abstract

OBJECTIVE: Formula feeding is associated with compromised intestinal health in preterm neonates compared with maternal milk, but the mechanisms behind this are unclear. We hypothesized that the use of maltodextrin and whey protein concentrates (WPCs) with reduced bioactivity owing to thermal processing are important factors.
METHOD: Ninety-two cesarean-delivered preterm pigs were fed increasing doses of formulas for 5 days (24-120 mL · kg · day). In experiment 1, 4 groups of pigs (n = 15-16) were fed lactose- or maltodextrin-dominant formulas (lactose/maltodextrin ratios 3:1 or 1:3, respectively), containing WPC with either high or low levels of IgG (WPC1 or WPC2, respectively). In experiment 2, 2 groups of pigs (n = 15-16) were fed lactose-dominant formulas with either a bioactive WPC (BioWPC, produced by reduced thermal-processing) or a conventional WPC (ConWPC).
RESULTS: In experiment 1, pigs fed formula with WPC1 had higher villi, hexose absorption, and lactase activity in small intestine, relative to WPC2, but predominantly with the lactose-dominant formula (all P < 0.05). In experiment 2, the BioWPC product had higher bioactivity, as indicated by higher IgG, lactoferrin, and TGF-β2 levels, and better enterocyte proliferation in vitro. Pigs fed the BioWPC formula showed better feeding tolerance and higher intestinal villi and lactase activity (all P < 0.05). The BioWPC formula-fed pigs also had greater physical activity (P < 0.05 on day 4) and tended to show improved hexose absorption and decreased gut permeability (both P ≤ 0.09).
CONCLUSIONS: Infant formulas containing lactose as the main carbohydrate, and WPC with reduced thermal processing, may support gut maturation and health in sensitive, preterm neonates.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28753186     DOI: 10.1097/MPG.0000000000001699

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Dose-response and functional role of whey permeate as a source of lactose and milk oligosaccharides on intestinal health and growth of nursery pigs.

Authors:  K Jang; J M Purvis; S W Kim
Journal:  J Anim Sci       Date:  2021-01-12       Impact factor: 3.159

2.  Dose-response and functional role of whey permeate as a source of lactose and milk oligosaccharides on intestinal health and growth of nursery pigs.

Authors:  Ki Beom Jang; Jerry M Purvis; Sung W Kim
Journal:  J Anim Sci       Date:  2021-01-01       Impact factor: 3.159

3.  Beneficial Effect of Mildly Pasteurized Whey Protein on Intestinal Integrity and Innate Defense in Preterm and Near-Term Piglets.

Authors:  Marit Navis; Vanesa Muncan; Per Torp Sangild; Line Møller Willumsen; Pim J Koelink; Manon E Wildenberg; Evan Abrahamse; Thomas Thymann; Ruurd M van Elburg; Ingrid B Renes
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

Review 4.  Human Milk Oligosaccharides to Prevent Gut Dysfunction and Necrotizing Enterocolitis in Preterm Neonates.

Authors:  Stine Brandt Bering
Journal:  Nutrients       Date:  2018-10-08       Impact factor: 5.717

5.  Bovine Colostrum Before or After Formula Feeding Improves Systemic Immune Protection and Gut Function in Newborn Preterm Pigs.

Authors:  Yanqi Li; Xiaoyu Pan; Duc Ninh Nguyen; Shuqiang Ren; Arshnee Moodley; Per Torp Sangild
Journal:  Front Immunol       Date:  2020-01-30       Impact factor: 7.561

6.  Mildly Pasteurized Whey Protein Promotes Gut Tolerance in Immature Piglets Compared with Extensively Heated Whey Protein.

Authors:  Marit Navis; Lauriane Schwebel; Susanne Soendergaard Kappel; Vanesa Muncan; Per Torp Sangild; Evan Abrahamse; Lise Aunsholt; Thomas Thymann; Ruurd M van Elburg; Ingrid B Renes
Journal:  Nutrients       Date:  2020-11-04       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.